Literature DB >> 19501004

Perspective: proteomic approach to detect biomarkers of human growth hormone.

Juan Ding1, Edward O List, Shigeru Okada, John J Kopchick.   

Abstract

Several serum biomarkers for recombinant human growth hormone (rhGH) have been established, however, none alone or in combination have generate a specific, sensitive, and reproducible 'kit' for the detection of rhGH abuse. Thus, the search for additional GH specific biomarkers continues. In this review, we focus on the use of proteomics in general and two-dimensional electrophoresis (2-DE) in particular for the discovery of new GH induced serum biomarkers. Also, we review some of the protocols involved in 2-DE. Finally, the possibility of tissues other than blood for biomarker discovery is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501004      PMCID: PMC2760539          DOI: 10.1016/j.ghir.2009.04.018

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  69 in total

1.  Detection of doping with human growth hormone.

Authors:  Z Wu; M Bidlingmaier; R Dall; C J Strasburger
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

2.  Differential exoprotease activities confer tumor-specific serum peptidome patterns.

Authors:  Josep Villanueva; David R Shaffer; John Philip; Carlos A Chaparro; Hediye Erdjument-Bromage; Adam B Olshen; Martin Fleisher; Hans Lilja; Edi Brogi; Jeff Boyd; Marta Sanchez-Carbayo; Eric C Holland; Carlos Cordon-Cardo; Howard I Scher; Paul Tempst
Journal:  J Clin Invest       Date:  2006-01       Impact factor: 14.808

3.  Human urine proteome analysis by three separation approaches.

Authors:  Wei Sun; Fuxin Li; Shuzhen Wu; Xiaorong Wang; Dexian Zheng; Jue Wang; Youhe Gao
Journal:  Proteomics       Date:  2005-12       Impact factor: 3.984

4.  Proteomics analysis of growth hormone isoforms in the human pituitary.

Authors:  Xianquan Zhan; Francesco Giorgianni; Dominic M Desiderio
Journal:  Proteomics       Date:  2005-04       Impact factor: 3.984

5.  Exploring the hidden human urinary proteome via ligand library beads.

Authors:  Annalisa Castagna; Daniela Cecconi; Lau Sennels; Juri Rappsilber; Luc Guerrier; Frederic Fortis; Egisto Boschetti; Lee Lomas; Pier Giorgio Righetti
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

6.  Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma.

Authors:  Lynn A Echan; Hsin-Yao Tang; Nadeem Ali-Khan; KiBeom Lee; David W Speicher
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

7.  Differentially expressed proteins in the pancreas of diet-induced diabetic mice.

Authors:  Linghua Qiu; Edward O List; John J Kopchick
Journal:  Mol Cell Proteomics       Date:  2005-06-16       Impact factor: 5.911

8.  Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults.

Authors:  Christer Ehrnborg; Lars Ellegård; Ingvar Bosaeus; Bengt-Ake Bengtsson; Thord Rosén
Journal:  Clin Endocrinol (Oxf)       Date:  2005-04       Impact factor: 3.478

9.  Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.

Authors:  Annika Berggren; Christer Ehrnborg; Thord Rosén; Lars Ellegård; Bengt-Ake Bengtsson; Kenneth Caidahl
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

10.  Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.

Authors:  J D Wallace; R C Cuneo; R Baxter; H Orskov; N Keay; C Pentecost; R Dall; T Rosén; J O Jørgensen; A Cittadini; S Longobardi; L Sacca; J S Christiansen; B A Bengtsson; P H Sönksen
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

View more
  14 in total

1.  Predicting response to growth hormone treatment.

Authors:  Leena Patel; Peter E Clayton
Journal:  Indian J Pediatr       Date:  2011-11-22       Impact factor: 1.967

2.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects.

Authors:  Juan Ding; Shigeru Okada; Jens Otto Lunde Jørgensen; John J Kopchick
Journal:  Proteomics       Date:  2011-07-27       Impact factor: 3.984

Review 3.  Hormones as doping in sports.

Authors:  Leonidas H Duntas; Vera Popovic
Journal:  Endocrine       Date:  2012-09-19       Impact factor: 3.633

4.  Serum proteome changes in acromegalic patients following transsphenoidal surgery: novel biomarkers of disease activity.

Authors:  Diana Cruz-Topete; Britt Christensen; Lucila Sackmann-Sala; Shigeru Okada; Jens Otto L Jorgensen; John J Kopchick
Journal:  Eur J Endocrinol       Date:  2010-11-08       Impact factor: 6.664

5.  Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome.

Authors:  Juan Ding; Edward O List; Brian D Bower; John J Kopchick
Journal:  Endocrinology       Date:  2011-07-26       Impact factor: 4.736

Review 6.  Mouse models of growth hormone action and aging: a proteomic perspective.

Authors:  Juan Ding; Lucila Sackmann-Sala; John J Kopchick
Journal:  Proteomics       Date:  2012-11-26       Impact factor: 3.984

7.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.

Authors:  Britt Christensen; Lucila Sackmann-Sala; Diana Cruz-Topete; Jens Otto L Jørgensen; Niels Jessen; Carsten Lundby; John J Kopchick
Journal:  J Appl Physiol (1985)       Date:  2010-10-21

8.  Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.

Authors:  Diana Cruz-Topete; Jens Otto L Jorgensen; Britt Christensen; Lucila Sackmann-Sala; Thomas Krusenstjerna-Hafstrøm; Adam Jara; Shigeru Okada; John J Kopchick
Journal:  J Clin Endocrinol Metab       Date:  2011-05-04       Impact factor: 5.958

9.  Elevated systolic blood pressure in male GH transgenic mice is age dependent.

Authors:  Adam Jara; Chance M Benner; Don Sim; Xingbo Liu; Edward O List; Lara A Householder; Darlene E Berryman; John J Kopchick
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

10.  Multiple protein biomarker assessment for recombinant bovine somatotropin (rbST) abuse in cattle.

Authors:  Susann K J Ludwig; Nathalie G E Smits; Grishja van der Veer; Maria G E G Bremer; Michel W F Nielen
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.